Lotus Pharmaceuticals Stock

Lotus Pharmaceuticals Liabilities 2024

Lotus Pharmaceuticals Liabilities

0 USD

Ticker

LTUS

ISIN

US5457152032

WKN

A1H5XJ

In 2024, Lotus Pharmaceuticals's total liabilities amounted to 0 USD, a 0% difference from the 0 USD total liabilities in the previous year.

Lotus Pharmaceuticals Aktienanalyse

What does Lotus Pharmaceuticals do?

The company Lotus Pharmaceuticals Inc was founded in 1976 and is based in Taiwan. The company operates in the pharmaceutical products sector and currently employs approximately 1,100 employees. Over the years, the company has become one of the leading providers of medications in the Taiwanese market. Lotus Pharma's business model is focused on the production, marketing, and sale of pharmaceutical products for the Taiwanese market. The company operates a comprehensive research and development department that specializes in the development of new medications for specific therapeutic applications. This department is also responsible for the continuous improvement and adaptation of existing medications. Lotus Pharma operates a range of different divisions within its organization. These include the marketing and distribution of innovative and generic medications, the sale of medical devices, and the development and production of natural remedies. Each division is focused on a specific group of customers and products. Lotus Pharma's product offering includes a wide range of pharmaceutical products developed for various therapeutic applications. These include medications for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other acute and chronic illnesses. All products have been developed and manufactured in accordance with applicable international quality standards. An important product of Lotus Pharma is the antithrombotic medication "Plavix," which is used to prevent blood clots in cases of heart attack and stroke. Lotus Pharma is the only authorized manufacturer of this medication for the Taiwanese market, giving it a strong market position in this area. In recent years, Lotus Pharma has also expanded its offering to include natural remedies. These are increasingly in demand by a growing number of people interested in alternative treatment methods. These products have all been developed based on traditional Chinese medicine principles and are based on natural ingredients. Lotus Pharma aims to improve the health and well-being of its customers. The company strives to offer high-quality pharmaceutical products that meet the needs of its customers and help them achieve their health goals. Through its comprehensive research and development efforts, as well as its top-notch production and marketing, Lotus Pharma has become a key player in the Taiwanese market and is expected to continue growing in the coming years. Lotus Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Lotus Pharmaceuticals's Liabilities

Lotus Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Lotus Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Lotus Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Lotus Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Lotus Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Lotus Pharmaceuticals stock

What is the level of liabilities of Lotus Pharmaceuticals this year?

Lotus Pharmaceuticals has a debt balance of 0 USD this year.

What were the liabilities of Lotus Pharmaceuticals compared to the previous year?

The liabilities of Lotus Pharmaceuticals have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Lotus Pharmaceuticals?

High liabilities can pose a risk for investors of Lotus Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Lotus Pharmaceuticals?

Low liabilities mean that Lotus Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Lotus Pharmaceuticals affect the company?

An increase in liabilities of Lotus Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Lotus Pharmaceuticals affect the company?

A decrease in the liabilities of Lotus Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Lotus Pharmaceuticals?

Some factors that can influence the liabilities of Lotus Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Lotus Pharmaceuticals so important for investors?

The liabilities of Lotus Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Lotus Pharmaceuticals take to modify the liabilities?

To change its liabilities, Lotus Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Lotus Pharmaceuticals pay?

Over the past 12 months, Lotus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lotus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Lotus Pharmaceuticals?

The current dividend yield of Lotus Pharmaceuticals is .

When does Lotus Pharmaceuticals pay dividends?

Lotus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lotus Pharmaceuticals?

Lotus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Lotus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lotus Pharmaceuticals located?

Lotus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceuticals from 11/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Lotus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Lotus Pharmaceuticals in the year 2023?

In the year 2023, Lotus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Lotus Pharmaceuticals pay out the dividend?

The dividends of Lotus Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceuticals

Our stock analysis for Lotus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.